Registered Nurse in Marshall, MO Accepting Medicare

5 Registered Nurse nurses found. Showing 1 - 5

Megan Leigh Shepard, CNM Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 2305 South 65 Highway, Building A, Marshall Women's Center, Marshall, MO 65340 Phone: 660-886-7800    Fax: 660-831-3346

Alyssa Beth Ferri, MSN, APRN, AGCNS-BC Registered Nurse - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 2305 South 65 Highway, Marshall, MO 65340 Phone: 660-886-7431    Fax: 660-886-9001

Emily Ann Braun, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2305 South 65 Highway, Marshall, MO 65340 Phone: 660-886-7431    Fax: 660-886-9001

Miranda Fitzpatrick, FNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 807 Cherokee Dr Ste 5, Marshall, MO 65340 Phone: 660-202-4227

Brian T Brown, CRNA Registered Nurse Medicare: Medicare Enrolled Practice Location: 2305 South 65 Highway, Marshall, MO 65340 Phone: 660-886-7431    Fax: 660-886-9001

News Archive

University of Melbourne becomes first University to head Secretariat of Movement for Global Mental Health

The University of Melbourne's Centre for International Mental Health is leading the way in addressing a desperately needed and often overlooked area of aid: mental health, by becoming the first University to head the Secretariat of the Movement for Global Mental Health.

Using NMR to investigate intrinsically disordered proteins: an interview with Dr Isabella Felli

"IDPs" is now a widely used acronym that stands for "intrinsically disordered proteins." It is the term generally used by the scientific community to refer to a wide variety of proteins that do not have a stable 3D structure and are instead characterized by a high extent of local mobility, disorder and many conformers that are accessible at room temperature.

Researchers develop two ultra-rapid tests for diagnosis of antibiotic resistance

With their excellent sensitivity and specificity, the use of these extremely efficient tests on a world-wide scale would allow us to adapt antibiotic treatments to the individual's needs and to be more successful in controlling antibiotic resistance, particularly in hospitals.

Lytix Biopharma granted Hungarian approval for Lytixar Phase IIa clinical trial in Gram positive skin infections

The Norwegian pharmaceutical company Lytix Biopharma AS today announces the approval in Hungary to commence a Phase IIa clinical trial with Lytixar (LTX-109) treatment of skin infections caused by Gram positive bacteria.

Read more Medical News

› Verified 4 days ago